PETER P. PFREUNDSCHUH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER P. PFREUNDSCHUH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER P. PFREUNDSCHUH. PETER P. PFREUNDSCHUH is a Chief Financial Officer in IMMUNOMEDICS INC ($IMMU) and a CFO in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Chief Financial Officer in UroGen Pharma Ltd. ($URGN) and a Chief Financial Officer in Frequency Therapeutics, Inc. ($FREQ).
Address: C/O IMMUNOMEDICS, INC. 300 AMERICAN ROAD MORRIS PLAINS 07950 NJ
Companies in which PETER P. PFREUNDSCHUH is an Insider
Frequency Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER P. PFREUNDSCHUH: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Apr 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNOMEDICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PETER P. PFREUNDSCHUH: Chief Financial Officer
Holdings: 29,706 shares
Current Value: $125,656
Latest Transaction: Aug 24 2015
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sucampo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER P. PFREUNDSCHUH: CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UroGen Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER P. PFREUNDSCHUH: Chief Financial Officer
Holdings: 12,805 shares
Latest Transaction: Oct 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER P. PFREUNDSCHUH
Sentiment: All, FREQ, IMMU, SCMP, URGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Jan 19 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 35.85 | 10,000 | 358,500 | 10,000 | |
| Jan 19 2021 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 35.85 | 10,000 | 358,500 | 10,000 | |
| Dec 03 2020 | FREQ | Frequency Therapeu ... | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 27.30 | 230,000 | 6,279,000 | 230,000 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,084 | 0 | 2,082 | |
| Oct 16 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 833 | 0 | 1,667 |